|
VPS13A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.547200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.742400E-01 |
| Normal-vs-Stage2 |
6.446800E-01 |
| Normal-vs-Stage3 |
4.525900E-02 |
| Normal-vs-Stage4 |
1.002470E-03 |
| Stage1-vs-Stage2 |
6.699800E-01 |
| Stage1-vs-Stage3 |
3.648200E-02 |
| Stage1-vs-Stage4 |
7.968900E-04 |
| Stage2-vs-Stage3 |
1.320230E-01 |
| Stage2-vs-Stage4 |
2.530500E-02 |
| Stage3-vs-Stage4 |
2.142000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.026400E-01 |
| Normal-vs-AfricanAmerican |
2.304100E-02 |
| Normal-vs-Asian |
9.243200E-01 |
| Caucasian-vs-AfricanAmerican |
6.879500E-02 |
| Caucasian-vs-Asian |
8.209200E-01 |
| AfricanAmerican-vs-Asian |
3.009600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.419400E-03 |
| Normal-vs-Female |
1.060980E-01 |
| Male-vs-Female |
6.18439999999776E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.075800E-03 |
| Normal-vs-Age(41-60Yrs) |
9.519200E-01 |
| Normal-vs-Age(61-80Yrs) |
7.707500E-02 |
| Normal-vs-Age(81-100Yrs) |
9.512200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.340190E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.224020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.170820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.532000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.400200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.936800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.561770E-01 |
| Normal-vs-Grade 2 |
4.465800E-01 |
| Normal-vs-Grade 3 |
1.464220E-01 |
| Normal-vs-Grade 4 |
4.96419999551634E-08 |
| Grade 1-vs-Grade 2 |
2.845000E-01 |
| Grade 1-vs-Grade 3 |
2.686300E-02 |
| Grade 1-vs-Grade 4 |
4.860500E-03 |
| Grade 2-vs-Grade 3 |
4.226100E-02 |
| Grade 2-vs-Grade 4 |
1.41139999687567E-08 |
| Grade 3-vs-Grade 4 |
2.4723999999976E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.822200E-04 |
| Normal-vs-ccB subtype |
1.37990000004251E-06 |
| ccA subtype-vs-ccB subtype |
1.72672987019951E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.207200E-01 |
| Normal-vs-N1 |
7.015500E-04 |
| N0-vs-N1 |
5.743500E-03 |
|
|
